针对WNT信号通路作为骨关节炎的新治疗策略
Zoya Iqbal1,2, Jiang Xia3, Ghulam Murtaza4
1Department of Orthopedics, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China.
Journal of drug targeting
|November 16, 2023
概括
针对无翼类型 (WNT) 信号通路显示出治疗骨关节炎 (OA) 的希望. 包括SM04690等抑制剂在内的WNT通路调节剂正在作为疾病修饰性骨关节炎药物 (DMOAD) 开发中.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎 (OA) 是一种常见的慢性关节疾病,导致严重的残疾,目前没有药物可以阻止关节损伤或疼痛.
- 无翼类型 (WNT) 信号通路在OA的进展和严重程度方面发挥着关键作用.
- 过度的WNT通路激活与OA的发展有关.
研究的目的:
- 审查OA药物开发的最新进展,以WNT信号通路为目标.
- 引入WNT通路,它们与OA中的其他信号通路的交叉通话,以及它们在OA发展中的监管作用.
- 突出针对OA治疗的WNT途径的治疗潜力和挑战.
主要方法:
- 关于OA中WNT信号的最近研究的文献综述.
- 在OA中分析WNT路径与其他信号级流交叉的分析.
- 检查WNT通路调节器作为潜在的OA治疗方法.
主要成果:
- WNT信号通路是OA发育中的关键调节器.
- 作为疾病修饰性骨关节炎药物 (DMOADs),WNT信号传递的抑制剂,如SM04690,显示出潜在的可能性.
- 目前正在探索基于纳米载体的输送系统,用于WNT调制器.
结论:
- 准WNT信号通路是OA的一种有前途的治疗策略.
- 需要进一步的研究和开发,以克服针对WNT的OA药物开发的挑战.
- WNT通路调制为开发新型OA治疗提供了一种独特的方法.
相关概念视频
02:54Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
01:41Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K